AMGN – amgen inc. (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day AMGN SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
10/30/2024
04:01 pm
amgn
amgen inc.
BEAT
1.5%
8/6/2024
04:01 pm
amgn
amgen inc.
BEAT
-5.0%
5/2/2024
04:01 pm
amgn
amgen inc.
BEAT
12.9%
2/6/2024
04:01 pm
amgn
amgen inc.
BEAT
-6.4%
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Top News Gainers
3/23 Amgen And The Amgen Foundation Commit Up To $12.5 Million To Support COVID-19 Relief Efforts 8.8%
8/8 Form 4 AMGEN INC For: Aug 07 Filed by: SUGAR RONALD D 6.2%
7/30 Amgen Reports Second Quarter 2019 Financial Results 6.1%
4/2 Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19 6.0%
8/26 UPDATE 2-Amgen to buy Celgene's psoriasis drug Otezla for $13.4 bln in cash [Reuters (UK)] 5.9%
4/7 Biotech Giant Amgen Entered The Coronavirus Arena — But Is It A Buy? [Investor's Business Daily] 5.9%
3/28 Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha® (Evolocumab) In People Living With HIV Who Have High LDL-Cholesterol 5.2%
8/12 Amgen, Inc. (NASDAQ: AMGN) had its "positive" rating re-affirmed by analysts at Wells Fargo & Co. They now have a $202.00 price target on the stock, up previously from $197.00. 5.0%
3/13 Amgen, Inc. (NASDAQ: AMGN) was upgraded by analysts at Cfra from a "hold" rating to a "buy" rating. 4.1%
3/26 Amgen, Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $250.00 to $240.00. They now have an "outperform" rating on the stock. 3.1%
Top News Decliners
3/14 Amgen, Inc. (NASDAQ: AMGN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -6.8%
3/7 Hedge Funds Have Never Been This Bullish On NVIDIA Corporation (NVDA) [Yahoo! Finance News] -5.8%
2/27 Amgen, Inc. (NASDAQ: AMGN) is now covered by analysts at Barclays PLC. They set an "equal weight" rating on the stock. -5.1%
3/24 Form 4 AMGEN INC For: Mar 20 Filed by: REESE DAVID M -4.6%
4/30 Form 8-K AMGEN INC For: Apr 30 -4.6%
1/30 Q4/2019 12/31/2019 EPS 3.640 ZacksConsensus 3.470 ActVsEst 0.170 - Beat -4.5%
2/25 Amgen Stock Is Forming A Flat Base — Is It Time To Bet On AMGN Stock? [Investor's Business Daily] -3.8%
8/2 Form 4 AMGEN INC For: Aug 01 Filed by: Santos Esteban -3.1%
3/10 Form 4 AMGEN INC For: Mar 09 Filed by: REESE DAVID M -2.8%
3/31 Form 8-K AMGEN INC For: Mar 31 -2.8%

Don’t Miss Out On The Next BIG Stock Move

Thanks for submitting the form.
AMGN – amgen inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
AMGN
SPY
QQQ
SPX
AMGN – amgen inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
AMGN SPY QQQ SPX
Stock Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Stock Stats
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
News
12/27
11:24 am
amgn
Low
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
12/24
10:29 am
amgn
Low
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income [Yahoo! Finance]
12/23
07:21 pm
amgn
Low
Here's Why Amgen (AMGN) Gained But Lagged the Market Today [Yahoo! Finance]
12/23
10:22 am
amgn
Low
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know [Yahoo! Finance]
12/20
09:04 am
amgn
Low
Bluenote Raises $10M from Lux Capital & Elad Gil to Transform Life Sciences Workflows with AI [Yahoo! Finance]
12/20
06:22 am
amgn
Low
Shaping the Future of Nutraceuticals: Trends, Innovations, and Market Outlook for 2024 and Beyond- Exclusive Report by MarketsandMarkets™ [Yahoo! Finance]
12/19
06:34 am
amgn
Low
Why Is Amgen Inc. (AMGN) Among the Best Dividend Stocks to Invest In? [Yahoo! Finance]
12/18
10:52 am
amgn
Low
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks [Yahoo! Finance]
12/18
02:03 am
amgn
Low
Amgen Inc. (NASDAQ: AMGN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
10/30/2024
04:01 pm
amgn
1.5%
BEAT
8/6/2024
04:01 pm
amgn
-5.0%
BEAT
5/2/2024
04:01 pm
amgn
12.9%
BEAT
2/6/2024
04:01 pm
amgn
-6.4%
BEAT
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
11/27
12:01 pm
Maintains
Outperform
Outperform
RBC Capital
Low
0.0%
11/27
12:01 pm
Maintains
Outperform
Outperform
RBC Capital
Low
0.0%
11/15
08:04 am
Initiates
Peer Perform
Wolfe Research
Medium
-4.2%
11/15
08:04 am
Initiates
Peer Perform
Wolfe Research
Medium
-4.2%
11/15
05:59 am
Upgrades
Hold
Citigroup Inc.
Medium
-3.5%
11/15
05:17 am
Initiates
Peer Perform
Wolfe Research
Medium
-3.5%
11/15
05:17 am
Initiates
Peer Perform
Wolfe Research
Medium
-3.5%
11/14
04:12 pm
Initiates
VIEW
WOLFE RESEARCH
Medium
-4.2%
11/14
04:12 pm
Initiates
VIEW
WOLFE RESEARCH
Medium
-4.2%
12/6
06:17 pm
amgn
Low
Form 4 AMGEN INC For: Dec 05 Filed by: Graham Jonathan P
12/3
07:49 pm
amgn
Low
Form 4 AMGEN INC For: Dec 02 Filed by: Bradway Robert A
11/6
07:47 pm
amgn
Low
Form 4 AMGEN INC For: Nov 05 Filed by: Khosla Rachna
11/6
07:45 pm
amgn
Low
Form 4 AMGEN INC For: Nov 05 Filed by: Busch Matthew C.
11/6
07:41 pm
amgn
Low
Form 4 AMGEN INC For: Nov 04 Filed by: ISHRAK OMAR
11/6
07:39 pm
amgn
Low
Form 4 AMGEN INC For: Nov 04 Filed by: HOLLEY CHARLES M
11/6
07:38 pm
amgn
Low
Form 4 AMGEN INC For: Nov 04 Filed by: Drake Michael V
10/31
06:02 am
amgn
Low
Form 10-Q AMGEN INC For: Sep 30
10/30
04:06 pm
amgn
Low
Form 8-K AMGEN INC For: Oct 30
Show more
Top News Gainers
3/23 Amgen And The Amgen Foundation Commit Up To $12.5 Million To Support COVID-19 Relief Efforts 8.8%
8/8 Form 4 AMGEN INC For: Aug 07 Filed by: SUGAR RONALD D 6.2%
7/30 Amgen Reports Second Quarter 2019 Financial Results 6.1%
4/2 Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19 6.0%
8/26 UPDATE 2-Amgen to buy Celgene's psoriasis drug Otezla for $13.4 bln in cash [Reuters (UK)] 5.9%
4/7 Biotech Giant Amgen Entered The Coronavirus Arena — But Is It A Buy? [Investor's Business Daily] 5.9%
3/28 Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha® (Evolocumab) In People Living With HIV Who Have High LDL-Cholesterol 5.2%
8/12 Amgen, Inc. (NASDAQ: AMGN) had its "positive" rating re-affirmed by analysts at Wells Fargo & Co. They now have a $202.00 price target on the stock, up previously from $197.00. 5.0%
3/13 Amgen, Inc. (NASDAQ: AMGN) was upgraded by analysts at Cfra from a "hold" rating to a "buy" rating. 4.1%
3/26 Amgen, Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $250.00 to $240.00. They now have an "outperform" rating on the stock. 3.1%
Top News Decliners
3/14 Amgen, Inc. (NASDAQ: AMGN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -6.8%
3/7 Hedge Funds Have Never Been This Bullish On NVIDIA Corporation (NVDA) [Yahoo! Finance News] -5.8%
2/27 Amgen, Inc. (NASDAQ: AMGN) is now covered by analysts at Barclays PLC. They set an "equal weight" rating on the stock. -5.1%
3/24 Form 4 AMGEN INC For: Mar 20 Filed by: REESE DAVID M -4.6%
4/30 Form 8-K AMGEN INC For: Apr 30 -4.6%
1/30 Q4/2019 12/31/2019 EPS 3.640 ZacksConsensus 3.470 ActVsEst 0.170 - Beat -4.5%
2/25 Amgen Stock Is Forming A Flat Base — Is It Time To Bet On AMGN Stock? [Investor's Business Daily] -3.8%
8/2 Form 4 AMGEN INC For: Aug 01 Filed by: Santos Esteban -3.1%
3/10 Form 4 AMGEN INC For: Mar 09 Filed by: REESE DAVID M -2.8%
3/31 Form 8-K AMGEN INC For: Mar 31 -2.8%